Interleukin-1 Beta-A Friend or Foe in Malignancies?

Bent R, Moll L, Grabbe S, Bros M. · 2018

Read Interleukin-1 Beta-A Friend or Foe in Malignancies? by Bent R, Moll L, Grabbe S, Bros M. (2018) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6121377.txt.

Introduction

Bent and co-authors wrote a review in International Journal of Molecular Sciences on interleukin-1 beta and cancer. Interleukin-1 beta is a signaling protein made by immune cells. It is switched on by a structure called the inflammasome. It helps the body clear sudden inflammation and fight tumors.

The review weighs its two-sided role in cancer. In chronic inflammation, the same signal can help tumors start. Inside tumors, it can spur new blood vessels and spread. It also helps grow cells that dampen immune attack. Mouse studies and drugs that block this signal support that view. The authors ask when blocking it may help patients.

Catalog record

CREATORBent R, Moll L, Grabbe S, Bros M.
YEAR2018
COLLECTIONPAPERS
FORMATTXT
FILE SIZE124 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC6121377

Browse the full library · About the Tower of Babel